VIQ Solutions Reports Third Quarter and Nine Months 2022 Financial Results
VIQ Solutions Inc. (VQS) reported Q3 2022 financial results with revenue of $11.8 million, up 66% year-over-year, driven by acquisitions. Gross profit was $5.6 million (47.3% margin), down from 51.4% in Q3 2021. The net loss improved to $1.3 million per share from $3.9 million a year earlier. For the first nine months, revenue reached $35.7 million, a 52% increase. The company revised its 2022 revenue guidance to $46-$47 million due to negative currency impacts and operational challenges.
- Q3 2022 revenue increased by 66% to $11.8 million.
- Acquisitions of Auscript and TTA contributed to revenue growth.
- Net loss improved from $3.9 million to $1.3 million year-over-year.
- Gross profit margin decreased to 47.3% from 51.4% in Q3 2021.
- Full year 2022 revenue guidance revised down to $46-$47 million.
- Negative impacts from foreign exchange rates and labor shortages.
“Our customers and the market are moving away from large technology purchases to buying and engaging on a monthly basis over the course of a contract. As a result, we are in the midst of a transition toward a subscription-based annual recurring revenue (ARR) model. Over time, we expect this will manifest in the financial results with higher revenue and overall margins, and more consistent monthly and annual revenues. Additionally, we believe it will improve the customer lifetime value,” said
“This past quarter we continued to transition our contract with the much-anticipated large customer in
Third Quarter 2022 Financial Highlights
-
Revenue of
compared to$11.8 million in the same quarter of 2021, up$7.1 million 66% , driven by the acquisition of Auscript inAustralia andThe Transcription Agency (“TTA”) in theUnited Kingdom . This was partially offset by negative foreign currency impacts on revenue outside of the US due to the appreciation of the US dollar relative to foreign currencies; -
Gross profit was
, or$5.6 million 47.3% of revenue, compared to , or$3.6 million 51.4% of revenue, in the same quarter of 2021. Excluding COVID-19 wage subsidies, Gross Profit Margin for Technology Services1 for the three months endedSeptember 30, 2022 , would be44.6% versus43.9% in the comparative period in 2021, which has increased due to productivity gains achieved through NetScribe, powered by aiAssist and our global workforce; -
Net loss was
, or$1.3 million per diluted share, versus net loss of$0.04 , or$3.9 million per diluted share, in the same quarter in 2021; and$0.15 -
Adjusted EBITDA1 was negative
versus a negative Adjusted EBITDA of$0.6 million in the third quarter of 2021. For a reconciliation of net loss to Adjusted EBITDA, please see the table at the end of this press release.$3.1 million
First Nine Months of 2022 Financial Highlights
-
Revenue of
compared to$35.7 million for the same period of 2021. The increase in revenue of$23.5 million 52% was driven by the acquisitions of Auscript and TTA, partially offset by negative currency impacts; -
Gross profit was
, or$17.1 million 48.1% of revenue, compared to , or$11.6 million 49.5% of revenue, for the same period of 2021. Excluding COVID-19 wage subsidies, Gross Profit Margin for Technology Services1 for the nine months endedSeptember 30, 2022 , would be45.9% versus40.5% in the comparative period in 2021, which has increased due to productivity gains achieved through NetScribe, powered by aiAssist; -
Net loss was
, or$6.5 million per diluted share, versus net loss of$0.21 , or$16.0 million per diluted share in the same period in 2021;$0.63 -
Adjusted EBITDA1 was negative
versus a negative Adjusted EBITDA of$2.2 million for the same period of 2021. For a reconciliation of net loss to Adjusted EBITDA, please see the table at the end of this press release; and$3.1 million -
Year to date Bookings1 of
, of which, approximately$7.1 million 10% were recognized as revenue up toSeptember 30, 2022 .
1 Represents a non-IFRS measure. Please refer to the "Non-IFRS Measures" section below and the reconciliation tables at the end of this press release.
“In addition to our acceleration to an annual recurring revenue model, we are currently focused on the integration of the
Revised Full Year 2022 Financial Goals:
The Company has revised its full year 2022 goals to be in the range of
Conference Call Details
VIQ will host a conference call and webcast to discuss its third quarter 2022 financial results on
Investors may access a live webcast of the call on the Company’s website at www.viqsolutions.com/investors or by dialing 1-888-440-4052 (
A replay of the webcast will be available on the Company’s website through the same link approximately one hour after the conference call concludes.
For more information about VIQ, please visit viqsolutions.com.
About
Forward-looking Statements
Certain statements included in this press release constitute forward-looking statements or forward-looking information (collectively, “forward-looking statements”) under applicable securities legislation, including, Section 27A of the
Forward-looking statements typically contain statements with words such as "anticipate", "believe", "expect", "plan", "intend", "estimate", "propose", "project" or similar words, including negatives thereof, suggesting future outcomes or that certain events or conditions “may” or “will” occur. These statements are only predictions. Forward-looking statements in this press release include, but are not limited to statements with respect to the implications of the Company transitioning towards a subscription-based ARR model, longer-term benefits resulting from the integration of Auscript, the Company’s focus on the integration of its
Forward-looking statements are based on several factors and assumptions which have been used to develop such statements, but which may prove to be incorrect. Although VIQ believes that the expectations reflected in such forward-looking statements are reasonable when made, undue reliance should not be placed on forward-looking statements because VIQ can give no assurance that such expectations will prove to be correct. In addition to other factors and assumptions which may be identified in this press release, assumptions have been made regarding, among other things, recent initiatives and that sales and prospects may provide increased revenue . Readers are cautioned that the foregoing list is not exhaustive of all factors and assumptions that have been used.
Forward-looking statements are necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by the Company as of the date of this press release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to the factors described in greater detail in the “Risk Factors” section of the Company’s annual information form dated
These factors are not intended to represent a complete list of the factors that could affect the Company, however, these factors should be considered carefully. Such estimates and assumptions may prove to be incorrect or overstated. The forward-looking statements contained in this press release are made as of the date of this press release and the Company expressly disclaims any obligations to update or alter such statements, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law. Although we do not currently expect these negative factors will be recurring, there can be no assurance that our financial performance goals will be achieved.
Financial Outlook
This press release contains a financial outlook within the meaning of applicable Canadian securities laws and such financial outlook contains “forward looking statements” within the meaning of Section 27A of the
Consolidated Statements of Financial Position
(Expressed in |
||||
|
|
|
||
Assets |
|
|
||
Current assets |
|
|
||
Cash |
$ |
3,854,773 |
$ |
10,583,534 |
Trade and other receivables, net of allowance for doubtful accounts |
|
5,696,881 |
|
5,594,368 |
Inventories |
|
33,149 |
|
49,557 |
Prepaid expenses and deposits |
|
2,040,125 |
|
2,054,793 |
Non-current assets |
|
11,624,928 |
|
18,282,252 |
Restricted cash |
|
466,443 |
|
303,945 |
Property and equipment |
|
1,084,690 |
|
460,974 |
Right of use assets |
|
775,717 |
|
1,134,493 |
Intangible assets |
|
12,162,277 |
|
14,762,140 |
|
|
11,881,278 |
|
12,595,323 |
Deferred tax assets |
|
468,202 |
|
464,800 |
Total assets |
$ |
38,463,535 |
$ |
48,003,927 |
Liabilities |
|
|
||
Current liabilities |
|
|
||
Trade and other payables and accrued liabilities |
$ |
6,390,545 |
$ |
5,692,924 |
Income tax payable |
|
347,333 |
|
97,784 |
Share based payment liability |
|
64,679 |
|
551,201 |
Derivative warrant liability |
|
1,043,515 |
|
1,862,876 |
Current portion of long-term debt |
|
878,886 |
|
1,109,713 |
Current portion of lease obligations |
|
291,664 |
|
287,901 |
Current portion of contract liabilities |
|
1,494,212 |
|
1,003,187 |
Non-current liabilities |
|
10,510,834 |
|
10,605,586 |
Deferred tax liability |
|
837,711 |
|
1,199,266 |
Long-term debt |
|
7,827,511 |
|
11,999,108 |
Long-term contingent consideration |
|
– |
|
166,603 |
Long-term lease obligations |
|
594,006 |
|
900,868 |
Other long-term liabilities |
|
1,052,611 |
|
1,042,938 |
Total liabilities |
|
20,822,673 |
|
25,914,369 |
Shareholders' Equity |
|
|
||
Capital stock |
|
74,232,063 |
|
72,191,764 |
Contributed surplus |
|
5,750,924 |
|
4,842,208 |
Accumulated other comprehensive income |
|
(785,192) |
|
74,526 |
Deficit |
|
(61,556,933) |
|
(55,018,940) |
Total shareholders’ equity |
|
17,640,862 |
|
22,089,558 |
Total liabilities and shareholders' equity |
$ |
38,463,535 |
$ |
48,003,927 |
Consolidated Statements of Loss and Comprehensive Loss
(Expressed in |
|||||||||
Three months ended |
Nine months ended |
||||||||
|
2022 |
2021 |
2022 |
2021 |
|||||
Revenue |
$ |
11,785,713 |
$ |
7,086,357 |
$ |
35,662,349 |
$ |
23,532,391 |
|
|
|
||||||||
Cost of Sales |
|
6,208,528 |
|
3,444,259 |
|
18,501,913 |
|
11,891,379 |
|
Gross Profit |
|
5,577,185 |
|
3,642,098 |
|
17,160,436 |
|
11,641,012 |
|
|
|
||||||||
|
|
||||||||
Selling and administrative expenses |
|
5,960,010 |
|
6,516,449 |
|
18,628,758 |
|
14,008,605 |
|
Research and development expenses |
|
164,849 |
|
317,546 |
|
642,291 |
|
817,219 |
|
Stock based compensation |
|
681,193 |
|
859,119 |
|
2,173,969 |
|
7,632,906 |
|
Gain on revaluation of options |
|
– |
|
(501,974) |
|
(1,063,662) |
|
(501,974) |
|
Gain on revaluation of RSUs |
|
(137,224) |
|
(119,012) |
|
(445,682) |
|
(119,012) |
|
Foreign exchange loss (gain) |
|
(151,354) |
|
(445,978) |
|
597,209 |
|
(77,252) |
|
Depreciation |
|
156,916 |
|
45,736 |
|
432,483 |
|
189,392 |
|
Amortization |
|
1,115,721 |
|
989,215 |
|
3,219,135 |
|
3,282,037 |
|
Interest expense |
|
234,892 |
|
329,598 |
|
815,733 |
|
996,611 |
|
Accretion and other financing costs |
|
466,316 |
|
236,309 |
|
755,596 |
|
755,970 |
|
Loss (gain) on contingent consideration |
|
11,807 |
|
(80,252) |
|
107,879 |
|
(66,977) |
|
Gain on revaluation of the derivative warrant liability |
|
(2,477,746) |
|
(763,499) |
|
(3,524,526) |
|
(763,499) |
|
Loss on extinguishment of debt |
|
747,865 |
|
– |
|
747,865 |
|
– |
|
Restructuring costs |
|
134,582 |
|
35,072 |
|
303,690 |
|
395,324 |
|
Business acquisition costs |
|
23,339 |
|
183,324 |
|
418,856 |
|
183,324 |
|
Other income |
|
(170) |
|
(2,226) |
|
(899) |
|
(10,520) |
|
|
6,930,996 |
|
7,599,427 |
|
23,808,695 |
|
26,722,154 |
||
|
|
||||||||
Current income tax (recovery) expense |
|
(97,827) |
|
(42,562) |
|
74,815 |
|
(41,204) |
|
Deferred income tax (recovery) expense |
|
73,956 |
|
(55,262) |
|
(185,081) |
|
985,018 |
|
Income tax (recovery) expense |
|
(23,871) |
|
(97,824) |
|
(110,266) |
|
943,814 |
|
Net loss for the period |
$ |
(1,329,940) |
$ |
(3,859,505) |
$ |
(6,537,993) |
$ |
(16,024,956) |
|
Exchange loss on translating foreign operations |
|
(823,213) |
|
(432,533) |
|
(859,718) |
|
(166,499) |
|
Comprehensive loss for the period |
$ |
(2,153,153) |
$ |
(4,292,038) |
$ |
(7,397,711) |
$ |
(16,191,455) |
|
|
|
||||||||
Net loss per share |
|
|
|||||||
Basic |
|
(0.04) |
|
(0.15) |
|
(0.21) |
|
(0.63) |
|
Diluted |
|
(0.04) |
|
(0.15) |
|
(0.21) |
|
(0.63) |
|
Weighted average number of common shares outstanding - basic |
|
32,749,800 |
|
26,359,517 |
|
30,854,262 |
|
25,292,160 |
|
Weighted average number of common shares outstanding - diluted |
|
32,749,800 |
|
26,359,517 |
|
30,854,262 |
|
25,292,160 |
Adjusted EBITDA
(Expressed in |
|||||||||
|
Three months ended |
|
Nine months ended |
||||||
(unaudited) |
2022 |
2021 |
|
2022 |
2021 |
||||
Net Loss |
$ |
(1,329,940) |
$ |
(3,859,505) |
|
$ |
(6,537,993) |
$ |
(16,024,956) |
Add: |
|
|
|
|
|
||||
Depreciation |
|
156,916 |
|
45,736 |
|
|
432,483 |
|
189,392 |
Amortization |
|
1,115,721 |
|
989,215 |
|
|
3,219,135 |
|
3,282,037 |
Interest expense |
|
234,892 |
|
329,598 |
|
|
815,733 |
|
996,611 |
Current income tax expense (recovery) |
|
(97,827) |
|
(42,562) |
|
|
74,815 |
|
(41,204) |
Deferred income tax expense (recovery) |
|
73,956 |
|
(55,262) |
|
|
(185,081) |
|
985,018 |
EBITDA |
|
153,718 |
|
(2,592,780) |
|
|
(2,180,908) |
|
(10,613,102) |
Accretion and other financing costs |
|
466,316 |
|
236,309 |
|
|
755,596 |
|
755,970 |
Gain on revaluation of options |
|
- |
|
(501,974) |
|
|
(1,063,662) |
|
(501,974) |
Gain on revaluation of RSUs |
|
(137,224) |
|
(119,012) |
|
|
(445,682) |
|
(119,012) |
Gain on revaluation of the derivative warrant liability |
|
(2,477,746) |
|
(763,499) |
|
|
(3,524,526) |
|
(763,499) |
Loss on extinguishment of debt |
|
747,865 |
|
- |
|
|
747,865 |
|
- |
Restructuring costs |
|
134,582 |
|
35,072 |
|
|
303,690 |
|
395,324 |
Business acquisition costs |
|
23,339 |
|
183,324 |
|
|
418,856 |
|
183,324 |
Other income |
|
(170) |
|
(2,226) |
|
|
(899) |
|
(10,520) |
Stock-based compensation |
|
681,193 |
|
859,119 |
|
|
2,173,969 |
|
7,632,906 |
Foreign exchange loss |
|
(151,354) |
|
(445,978) |
|
|
597,209 |
|
(77,252) |
|
|
|
|
|
|
||||
Adjusted EBITDA |
$ |
(559,481) |
$ |
(3,111,645) |
|
$ |
(2,218,492) |
$ |
(3,117,835) |
Non-IFRS Measures
EBITDA, Adjusted EBITDA, and Bookings, are not measures recognized by IFRS and do not have standardized meanings prescribed by IFRS. Therefore, these terms as used by VIQ may not be comparable to similar measures presented by other issuers. Investors are cautioned that EBITDA and Adjusted EBITDA should not be construed as an alternative to net income (loss) as determined in accordance with IFRS.
The Company prepares its financial statements in accordance with IFRS. Non-IFRS measures are used by management to provide additional insight into our performance and financial condition. We believe non-IFRS measures are an important part of the financial reporting process and are useful in communicating information that complements and supplements the consolidated financial statements. This news release also includes certain measures which have not been prepared in accordance with IFRS such as Adjusted EBITDA, and Bookings.
To evaluate the Company’s operating performance as a complement to results provided in accordance with IFRS, the term “EBITDA” refers to net income (loss) before adjusting earnings for depreciation, amortization, interest expense, and current and deferred income tax expense. The term “Adjusted EBITDA” refers to net income (loss) before adjusting earnings for stock-based compensation, depreciation, amortization, interest expense, accretion and other financing expense, (gain) loss on revaluation of options, (gain) loss on revaluation of restricted share units, gain (loss) on revaluation of derivative warrant liability, restructuring costs, (gain) loss on revaluation of conversion feature liability, loss on repayment of long-term debt, business acquisition costs, impairment of goodwill and intangibles, other expense (income), foreign exchange (gain) loss, and current and deferred income tax expense. We believe that the items excluded from EBITDA and Adjusted EBITDA are not connected to and do not represent the operating performance of the Company. The term “Bookings” refers to the annualized estimated monthly value of our recurring client contracts entered into during the period from (i) new clients and (ii) net upgrades by existing clients within the same workload, plus the actual (not annualized) estimated value of professional services consulting, advisory or project-based orders received during the period. Recurring client contracts are any contracts entered into on a multi-year or month-to-month basis, but excluding any professional services contracts for consulting, advisory or project-based work.
We believe that Adjusted EBITDA is useful supplemental information as it provides an indication of the results generated by the Company’s main business activities prior to taking into consideration how those activities are financed and taxed as well as expenses related to stock-based compensation, depreciation, amortization, impairment of goodwill and intangibles, other expense (income), and foreign exchange (gain) loss. Accordingly, we believe that this measure may also be useful to investors in enhancing their understanding of the Company’s operating performance.
We believe that Bookings is useful supplemental information as it measures the amount of new business generated in a period, which we believe is an important indicator of new client acquisition and our ability to cross-sell new services to existing clients. While we believe Bookings, in combination with other metrics, is an indicator of our near-term future revenue opportunity, it is not intended to be used as a projection of future revenue. Our calculation of Bookings may differ from similarly titled metrics presented by other companies.
We believe Gross Margin for Technology Services without Covid 19 Subsidies is useful supplemental information as it provides an indication of the cost of sales and gross margin generated by the Company’s technology segment excluding the impact of Covid 19 subsidies.
For a reconciliation and/or calculation of Adjusted EBITDA, Bookings and Gross Margin for Technology Services without Covid 19 subsidies please refer to the section entitled "Key Operating Metrics – Non-IFRS Measures" in the Company's management's discussion and analysis for the three and nine months ended
Trademarks
This press release includes trademarks, such as “NetScribe, and “aiAssist,” which are protected under applicable intellectual property laws and are the property of VIQ. Solely for convenience, our trademarks referred to in this press release may appear without the ® or TM symbol, but such references are not intended to indicate, in any way, that we will not assert our rights to these trademarks, trade names and services marks to the fullest extent under applicable law. Trademarks which may be used in this press release, other than those that belong to VIQ, are the property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221109006108/en/
Media:
Chief Marketing Officer
Phone: (800) 263-9947
Email: marketing@viqsolutions.com
Investor Relations:
High Touch Investor Relations
Phone: 1-914-598-7733
Email: viq@htir.net
Source:
FAQ
What are VIQ Solutions' Q3 2022 financial results?
How did VIQ Solutions' gross profit change in Q3 2022?
What is VIQ Solutions' revised revenue guidance for 2022?